Clinical Trial Update: A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations [Phase 2]

View source ↗

Summary

A completed Phase 2 dose-ranging study evaluated the efficacy and safety of AZD8630 at multiple doses in adults with uncontrolled asthma at risk of exacerbation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AZD8630

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 2 | Status: COMPLETED